Skip to content

The effect of Nigella sativa on Meniere's disease

Evaluation of the effect of Nigella sativa consumption on improving the symptoms of Meniere's disease in Meniere's patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201102049238N1
Enrollment
40
Registered
2021-01-13
Start date
2021-04-06
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere's disease. Meniere's disease, unspecified ear

Interventions

Intervention 1: Intervention group: capsules containing 1 gram of Nigella sativa oil, oral consumption, 1 gram per day for 3 months, Barij Essence company+ continuation of the previous basic treatment

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are definite cases of Meniere's disease

Exclusion criteria

Exclusion criteria: History of cardiac disease History of hepatic disease History of renal disease History of psychiatric disease History of hypertension disease

Design outcomes

Primary

MeasureTime frame
Improvement of tinnitus. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Tinnitus Handicap Inventory questionnaire.;Improvement of hearing loss. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Audiometry.;Improvement of vertigo. Timepoint: At the beginning of the study and 3 months after starting the consumption of Nigella sativa. Method of measurement: Dizziness Handicap Inventory questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Rabbani

Tehran University of Medical Sciences

z.rabbani1@gmail.com+98 21 8601 3261

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026